Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krakauer

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Neurology|June 26, 2001
Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosisJ Jensen, M Krakauer, F Sellebjerg
Journal of Neuroimmunology|November 4, 2006
CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosisM Krakauer, P S Sorensen, F Sellebjerg
Acta Neurologica Scandinavica|October 24, 1998
Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosisM Krakauer, H Schaldemose Nielsen, J Jensen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expressionM Krakauer, P Sorensen, M Khademi, et al.
Clinical and Experimental Immunology|October 9, 2012
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosisF Sellebjerg, M Krakauer, M Khademi, et al.
Scandinavian Journal of Immunology|July 27, 2006
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosisM Krakauer, P S Sorensen, M Khademi, et al.
Journal of Ophthalmology|April 24, 2012
Adverse effects of systemic immunosuppression in keratolimbal allograftM Krakauer, J D Welder, H K Pandya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosisF Sellebjerg, D Hesse, S Limborg, et al.
Neurology|December 10, 2009
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MSF Sellebjerg, L Börnsen, M Khademi, et al.
European Journal of Neurology|June 22, 2010
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?D Hesse, M Krakauer, H Lund, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Neurology|June 26, 2001
Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosisJ Jensen, M Krakauer, F Sellebjerg
Journal of Neuroimmunology|November 4, 2006
CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosisM Krakauer, P S Sorensen, F Sellebjerg
Acta Neurologica Scandinavica|October 24, 1998
Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosisM Krakauer, H Schaldemose Nielsen, J Jensen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expressionM Krakauer, P Sorensen, M Khademi, et al.
Clinical and Experimental Immunology|October 9, 2012
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosisF Sellebjerg, M Krakauer, M Khademi, et al.
Scandinavian Journal of Immunology|July 27, 2006
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosisM Krakauer, P S Sorensen, M Khademi, et al.
Journal of Ophthalmology|April 24, 2012
Adverse effects of systemic immunosuppression in keratolimbal allograftM Krakauer, J D Welder, H K Pandya, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosisF Sellebjerg, D Hesse, S Limborg, et al.
Neurology|December 10, 2009
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MSF Sellebjerg, L Börnsen, M Khademi, et al.
European Journal of Neurology|June 22, 2010
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?D Hesse, M Krakauer, H Lund, et al.
Pageof 2